東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

New therapeutic strategies for type ...

Jones, Robert M.

FindBook

Google Book

Amazon

博客來

New therapeutic strategies for type 2 diabetes : = small molecule approaches /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	New therapeutic strategies for type 2 diabetes :/ edited by Robert M. Jones.
其他題名:	small molecule approaches /
其他作者:	Jones, Robert M.
出版者:	Cambridge :RSC Pub., : c2012.,
面頁冊數:	xv, 515 p. :ill. (some col.) ;24 cm.
標題:	Diabetes - Treatment. -
ISBN:	9781849734141 (hbk.) :
ISSN:	20413203

New therapeutic strategies for type 2 diabetes : = small molecule approaches /
New therapeutic strategies for type 2 diabetes :small molecule approaches /edited by Robert M. Jones. - Cambridge :RSC Pub.,c2012. - xv, 515 p. :ill. (some col.) ;24 cm. - RSC drug discovery series ;27..

Includes bibliographical references and index.

Type 2 diabetes: disease overview /Daniel M. Kemp --

ISBN: 9781849734141 (hbk.) :UK159.99

ISSN: 20413203Subjects--Topical Terms:

841790
Diabetes
--Treatment.

LC Class. No.: RA645.D5 / N49 2012

New therapeutic strategies for type 2 diabetes : = small molecule approaches /
LDR:02461cam a2200229 a 4500 001 1348747
003 OCoLC
005 20130117020642.0
008 130502s2012 enka b 001 0 eng d
020 $a 9781849734141 (hbk.) : $c UK159.99
020 $a 1849734143 (hbk.)
020 $a 9781849735322 (ebk.)
020 $a 1849735328 (ebk.)
022 $a 20413203
035 $a CS-BW-102-N-03
040 $a BTCTA $b eng
050 # 4 $a RA645.D5 $b N49 2012
245 1 0 $a New therapeutic strategies for type 2 diabetes : $b small molecule approaches / $c edited by Robert M. Jones.
260 # $a Cambridge : $b RSC Pub., $c c2012.
300 $a xv, 515 p. : $b ill. (some col.) ; $c 24 cm.
490 1 0 $a RSC drug discovery series ; $v 27.
504 $a Includes bibliographical references and index.
505 0 # $t Type 2 diabetes: disease overview / $r Daniel M. Kemp -- $t Marketed small molecule dipeptidyl peptidase IV (DPP4) inhibitors as a new class of oral anti-diabetics / $r Zhonghua Pei -- $t SGLT2 inhibitors in development / $r William N. Washburn -- $t Glucokinase activators in development / $r Kevin J. Filipski, Benjamin D. Stevens and Jeffrey A. Pfefferkorn -- $t 11[beta]-hydroxysteroid dehydrogenase type 1 (11[beta]-HSD1) inhibitors in development / $r James S. Scott and Jasen Chooramun -- $t Recent advances in PTP1B inhibitor development for the treatment of type 2 diabetes and obesity / $r Rongjun He, Li-Fan Zeng, Yantao He and Zhong-Yin Zhang -- $t Recent advances in the discovery of GPR119 agonists / $r Unmesh Shah, Scott Edmondson and Jason W. Szewczyk -- $t Acyl-CoA : diacylglycerol acyltransferase-1 inhibition as an approach to the treatment of type 2 diabetes / $r Robert L. Dow -- $t Stearoyl-CoA desaturase 1 (SCD1) inhibitors : bench to bedside must only go through liver / $r Gang Liu -- $t TGR5 agonists in development / $r Antonio Macchiarulo, Antimo Gioiello and Roberto Pellicciari -- $t The discovery and development of MB07803, a second generation fructose-1,6-bisphosphatase inhibitor with improved pharmacokinetic properties, as a potential treatment of type 2 diabetes / $r Qun Dang, Paul D. van Poelje and Mark D. Erion -- $t Inhibition of glycogen phosphorylase as a strategy for the treatment of type 2 diabetes / $r Brad R. Henke -- $t SIRT1 activators in development / $r Robert B. Perni ... [et al.] -- $t Long-chain free fatty acid receptor agonists / $r Jonathan B. Houze -- $t Glucagon receptor antagonists in development / $r Duane E. DeMong and M. W. Miller -- $t ACC inhibitors in development / $r Matthew P. Bourbeau.
650 # 0 $a Diabetes $x Treatment. $3 841790
650 # 2 $a Diabetes Mellitus, Type 2 $x drug therapy. $3 1959514
650 # 2 $a Drug Discovery. $3 1359836
700 1 # $a Jones, Robert M. $3 1959513
710 2 # $a Royal Society of Chemistry (Great Britain) $3 515130